Cibenzoline ( DrugBank: Cibenzoline )


1 disease
IDDisease name (Link within this page)Number of trials
58Hypertrophic cardiomyopathy1

58. Hypertrophic cardiomyopathy


Clinical trials : 119 Drugs : 163 - (DrugBank : 45) / Drug target genes : 48 - Drug target pathways : 161
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-JapicCTI-194910
18/9/201908/08/2019Phase II clinical study of TY-0305 in symptomatic patients with hypertrophic obstructive cardiomyopathy -A pilot study-Phase II clinical study of TY-0305 in symptomatic patients with hypertrophic obstructive cardiomyopathy -A pilot study- Symptomatic hypertrophic obstructive cardiomyopathyIntervention name : TY-0305
INN of the intervention : Cibenzoline
Dosage And administration of the intervention : Two tablets orally of TY-0305 50mg twice or three times daily
Control intervention name : -
INN of the control intervention : -
Dosage And administration of the control intervention : -
TOA EIYO LTD.NULLrecruiting2075BOTH10Phase 2Japan